Targeting microbial pathogenic mechanisms as a novel therapeutic strategy in IBD
Abstract Background Current therapy for patients suffering from inflammatory bowel diseases (IBD) is focused on inflammatory mechanisms exclusively and not the dysbiotic microbiota, despite growing evidence implicating a role for intestinal microbes in disease. Main body Ongoing research into the in...
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2024-08-01
|
| Rangatū: | Molecular Medicine |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s10020-024-00840-9 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|